Massachusetts Financial Services’s Kymera Therapeutics KYMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$17.4M Sell
209,005
-80,399
-28% -$6.37M 0.01% 665
2025
Q4
$22.5M Sell
289,404
-145,610
-33% -$9.83M 0.01% 629
2025
Q3
$24.6M Sell
435,014
-52,947
-11% -$2.39M 0.01% 602
2025
Q2
$21.3M Buy
487,961
+67,916
+16% +$2.34M 0.01% 609
2025
Q1
$11.5M Buy
420,045
+555
+0.1% +$20.2K ﹤0.01% 650
2024
Q4
$16.9M Sell
419,490
-33,887
-7% -$1.53M 0.01% 620
2024
Q3
$21.5M Buy
453,377
+47,507
+12% +$2.1M 0.01% 586
2024
Q2
$12.1M Buy
405,870
+10,731
+3% +$372K ﹤0.01% 625
2024
Q1
$15.9M Sell
395,139
-67,536
-15% -$2.42M ﹤0.01% 599
2023
Q4
$11.8M Sell
462,675
-858
-0.2% -$15.3K ﹤0.01% 614
2023
Q3
$6.44M Buy
463,533
+86,585
+23% +$1.74M ﹤0.01% 645
2023
Q2
$8.67M Buy
376,948
+37,801
+11% +$1.08M ﹤0.01% 617
2023
Q1
$10M Buy
+339,147
New +$10.9M ﹤0.01% 611

Other funds holding KYMR